Stockreport

Clovis Oncology Announces Product Revenues for the Fourth Quarter and Full Year 2018

Clovis Oncology, Inc.  (CLVS) 
Last clovis oncology, inc. earnings: 2/24 04:05 pm Check Earnings Report
PDF Estimated $30.3-$30.8M in Rubraca® sales for Q4 2018 and $95.3-$95.8M for FY2018 Q4/FY2018 Operating Results planned for February [Read more]